Becton Dickinson (BDX)
245.06
0.00 (0.00%)
Becton Dickinson is a global medical technology company that specializes in the development and manufacture of medical devices, instrument systems, and reagents
The company focuses on improving patient care and advancing healthcare delivery through its diverse product offerings, which include syringes, needles, blood collection systems, and diagnostic tools. With a strong commitment to innovation and quality, Becton Dickinson serves healthcare professionals and institutions around the world, facilitating safe and effective medical procedures and enhancing the overall health and well-being of patients.
![](https://mms.businesswire.com/media/20250123616589/en/1883739/22/Biosero_Logo.jpg)
BD (Becton, Dickinson and Company) (NYSEBDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.
By Biosero, Inc. · Via Business Wire · January 23, 2025
![](https://ml.globenewswire.com/media/ea9d2fb8-12c5-45f9-b357-d0e6258066f2/small/maravai-logo-jpg.jpg)
Carl Hull to Retire as Executive Chairman
By Maravai LifeSciences Holdings LLC · Via GlobeNewswire · December 5, 2024
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024
Via MarketBeat · May 4, 2024
Becton Dickinson and Company (NYSE: BDX) is a Leading Gainer in Monday Morning Trading
Becton, Dickinson And Company (NYSEBDX) is one of today’s top gainers. The company’s shares are currently up 6.3% on the day to $281.53.
Via Investor Brand Network · July 24, 2023
![](https://www.marketbeat.com/logos/articles/med_20240430092737_boston-scientific-bucks-the-medtech-slow-down-and.jpg)
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Via MarketBeat · April 30, 2024
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQSTSS),NYSE:STVNNYSESTVN)(NYSE:WSTNYSEWST,(NYSE:BDXNYSE),(NYSE:PFEPFE) EQNX::TICKER_END
Via FinancialNewsMedia · September 26, 2023
![](https://www.marketbeat.com/logos/articles/med_20230530065817_intuitive-surgical-gives-buying-opportunity-off-it.jpg)
Intuitive Surgical (NASDAQISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning
Via MarketBeat · May 30, 2023
![](https://www.marketbeat.com/logos/articles/small_20230314095754_healthcare-stocks-with-at-least-30-years-of-divide.jpg)
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
Via MarketBeat · March 14, 2023
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga
Via TheNewswire.com · March 1, 2023
![](https://www.marketbeat.com/logos/articles/small_20230228134930_lucira-stock-jumps-over-250-on-fda-approval-beware.jpg)
Lucira Health Inc. (NASDAQLHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via MarketBeat · March 1, 2023
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga
Via TheNewswire.com · January 17, 2023
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
EQNX::TICKER_START (NASDAQSTSS),NYSE:BDXNYSEBDX)(NYSE:CAHNYSECAH,(NYSE:NVONYSE),(OTCPK:TRUMY),(NASDAQ:STSSWSTSSW) EQNX::TICKER_END
Via FinancialNewsMedia · January 12, 2023
![](https://www.marketbeat.com/logos/articles/small_stock-image_447125394_S.jpg)
Heart disease equipment maker Edwards Life Sciences (NYSEEW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
Via MarketBeat · November 7, 2022
![](https://www.marketbeat.com/logos/articles/small_stock-image_599557704_S.jpg)
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQISRG) is turning 22 years old since its U.S. Food and Drug
Via MarketBeat · November 1, 2022
![](https://mms.businesswire.com/media/20221017006035/en/1319210/5/LOGO-BLEU.jpg)
Regulatory News:
By BIOCORP · Via Business Wire · October 18, 2022
![](https://www.marketbeat.com/logos/articles/small_stock-image_142159258_S.jpg)
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs.
Via MarketBeat · September 21, 2022
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up authorization, especially in the wake of a shortage. A study from Kaiser […]
Via FinancialNewsMedia · November 9, 2021
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction, better known as the PCR test, to detect Covid-19. Mass testing is becoming […]
Via FinancialNewsMedia · October 20, 2021
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
FN Media Group Presents USA News Group News Commentary
Via FinancialNewsMedia · September 28, 2021